• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童囊性纤维化的口服葡萄糖耐量试验。

Oral glucose tolerance testing in children with cystic fibrosis.

机构信息

Department of Pediatrics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Pediatr Diabetes. 2010 Nov;11(7):487-92. doi: 10.1111/j.1399-5448.2009.00632.x.

DOI:10.1111/j.1399-5448.2009.00632.x
PMID:20202149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3856892/
Abstract

BACKGROUND

Cystic fibrosis (CF) related diabetes is the most common comorbidity in persons with CF. International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines recommend annual oral glucose tolerance testing (OGTT) screening starting at age 10. The OGTT might be recommended in younger children if, as in adults, it provided clinically relevant prognostic information. A database review was performed to determine whether OGTT findings in children with CF predict subsequent clinical course.

METHODS

A retrospective matched-pair cohort study was based on OGTTs performed during 1998-2003. Children aged 6-9 were classified as having normal glucose tolerance (NGT) or abnormal glucose tolerance (AGT). Children with AGT were matched by age and gender to those with NGT. Clinical status was assessed at baseline and 5 yr later. In a separate investigation, diabetes and prior AGT status of children aged 10-18 were used to assess predictions derived from the cohort study.

RESULTS

In 1998-2003, 39 of 94 children had AGT. Of these, 31 had sufficient follow-up data to be included. Both at baseline and 5 yr later there was no significant difference in height, weight, body mass index (BMI) or lung function between AGT and NGT. Diabetes developed in 13 AGT (42%) and one NGT (3%) [odds ratio (OR) 11, p = 0.0009]. Age of diabetes onset was 12 ± 1 yr in boys and 11 ± 1 yr in girls, compared to approximately 23 yr in the general CF population. Fifteen current children age 10-18 who had AGT before age 10 have diabetes, close to the prediction of 19.

CONCLUSIONS

AGT in children with CF age 6-9 yr identifies those at high risk for progression to early onset diabetes.

摘要

背景

囊性纤维化(CF)相关糖尿病是 CF 患者最常见的合并症。国际儿科青少年糖尿病学会(ISPAD)指南建议从 10 岁开始每年进行口服葡萄糖耐量试验(OGTT)筛查。如果像在成年人中一样,OGTT 提供了有临床意义的预后信息,那么可能会建议在年龄较小的儿童中进行检查。进行了数据库回顾,以确定 CF 患儿的 OGTT 结果是否可预测随后的临床病程。

方法

回顾性匹配对队列研究基于 1998-2003 年进行的 OGTT。6-9 岁的儿童被分为正常葡萄糖耐量(NGT)或异常葡萄糖耐量(AGT)。通过年龄和性别与 NGT 相匹配的 AGT 儿童。在基线和 5 年后评估临床状况。在另一项研究中,根据队列研究,使用 10-18 岁儿童的糖尿病和先前的 AGT 状态评估预测结果。

结果

在 1998-2003 年,94 名儿童中有 39 名出现 AGT。其中,有 31 名有足够的随访数据被纳入。在基线和 5 年后,AGT 和 NGT 之间在身高、体重、体重指数(BMI)或肺功能方面均无显著差异。在 31 名 AGT 儿童中,有 13 名(42%)发生了糖尿病,而在 3 名 NGT 儿童中,有 1 名(3%)[比值比(OR)为 11,p=0.0009]。男孩的糖尿病发病年龄为 12 ± 1 岁,女孩为 11 ± 1 岁,而普通 CF 人群的发病年龄约为 23 岁。目前有 15 名 10-18 岁的儿童在 10 岁之前出现过 AGT,已患有糖尿病,接近预测值 19。

结论

6-9 岁 CF 儿童的 AGT 可识别出那些有进展为早发糖尿病高风险的患者。

相似文献

1
Oral glucose tolerance testing in children with cystic fibrosis.儿童囊性纤维化的口服葡萄糖耐量试验。
Pediatr Diabetes. 2010 Nov;11(7):487-92. doi: 10.1111/j.1399-5448.2009.00632.x.
2
[Abnormal glucose tolerance in prepubertal patients with cystic fibrosis].[青春期前囊性纤维化患者的糖耐量异常]
An Pediatr (Barc). 2012 Nov;77(5):339-43. doi: 10.1016/j.anpedi.2012.05.015. Epub 2012 Jun 27.
3
Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.口服葡萄糖耐量试验和持续葡萄糖监测以评估囊性纤维化患者糖尿病的发生情况。
Endocrinol Diabetes Nutr (Engl Ed). 2018 Jan;65(1):45-51. doi: 10.1016/j.endinu.2017.08.008. Epub 2017 Nov 12.
4
Glucose intolerance in children with cystic fibrosis: a developing country's perspective.囊性纤维化患儿的葡萄糖不耐受:一个发展中国家的视角
J Pediatr Endocrinol Metab. 2018 Oct 25;31(10):1139-1146. doi: 10.1515/jpem-2018-0222.
5
Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.口服葡萄糖耐量试验预测未来的囊性纤维化相关性糖尿病。
J Cyst Fibros. 2014 Jan;13(1):80-5. doi: 10.1016/j.jcf.2013.06.001. Epub 2013 Jun 25.
6
[Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].[持续葡萄糖监测在囊性纤维化患者糖尿病筛查中的价值]
Arch Pediatr. 2009 Dec;16(12):1540-6. doi: 10.1016/j.arcped.2009.09.007. Epub 2009 Oct 24.
7
Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.重视口服葡萄糖耐量试验筛查,以早期诊断囊性纤维化相关性糖尿病。
Pediatr Diabetes. 2014 Jun;15(4):309-12. doi: 10.1111/pedi.12094. Epub 2013 Nov 21.
8
The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.囊性纤维化患儿葡萄糖不耐受的病程:一项回顾性研究——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):80-91.
9
Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.囊性纤维化患者葡萄糖不耐受的自然史:十年前瞻性观察计划。
J Pediatr. 2010 Apr;156(4):613-7. doi: 10.1016/j.jpeds.2009.10.019. Epub 2009 Dec 3.
10
Early onset of abnormal glucose tolerance in patients with cystic fibrosis: A systematic review and meta-analysis.早发异常葡萄糖耐量在囊性纤维化患者中的表现:系统综述和荟萃分析。
J Cyst Fibros. 2024 Jul;23(4):616-624. doi: 10.1016/j.jcf.2024.02.010. Epub 2024 Mar 7.

引用本文的文献

1
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.胰腺内分泌和外分泌信号传导以及生理和病理状态下的相互作用。
Signal Transduct Target Ther. 2025 Feb 14;10(1):39. doi: 10.1038/s41392-024-02098-3.
2
Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study.低升糖负荷饮食干预对成年囊性纤维化患者的安全性和耐受性:一项试点研究。
Front Nutr. 2024 Sep 25;11:1441201. doi: 10.3389/fnut.2024.1441201. eCollection 2024.
3
Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.连续血糖监测和晚期糖基化终产物预测成人 CF 相关糖尿病的临床结局和发展。
Front Endocrinol (Lausanne). 2024 Feb 6;15:1293709. doi: 10.3389/fendo.2024.1293709. eCollection 2024.
4
Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.囊性纤维化中的胰腺和胰岛形态:囊性纤维化相关糖尿病病因的线索。
Front Endocrinol (Lausanne). 2023 Nov 23;14:1269139. doi: 10.3389/fendo.2023.1269139. eCollection 2023.
5
Clinical Observations in Patients With Cystic Fibrosis-Related Diabetes and Self-Reported Ototoxicity Symptoms.囊性纤维化相关糖尿病患者及自我报告耳毒性症状患者的临床观察
Am J Audiol. 2023 Nov 28;33(1):1-9. doi: 10.1044/2023_AJA-22-00237.
6
Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes.传感器增强型胰岛素泵优化胰岛素治疗对囊性纤维化相关性糖尿病患者血糖控制和身体成分的影响。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1228153. doi: 10.3389/fendo.2023.1228153. eCollection 2023.
7
Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response.持续葡萄糖监测作为早期囊性纤维化相关糖尿病监测及短期西他列汀反应评估的辅助工具
Biomedicines. 2023 Jun 19;11(6):1754. doi: 10.3390/biomedicines11061754.
8
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.囊性纤维化相关性糖尿病研讨会:涵盖疾病病理生理学、诊断和结局的研究重点。
Diabetes Care. 2023 Jun 1;46(6):1112-1123. doi: 10.2337/dc23-0380.
9
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.囊性纤维化相关性糖尿病研讨会:涵盖疾病病理生理学、诊断和结局的研究重点。
Diabetes. 2023 Jun 1;72(6):677-689. doi: 10.2337/db22-0949.
10
Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis.在患有囊性纤维化的青少年和成年人中,使用依列卡福/替扎卡福/依伐卡福前后的血糖水平和β细胞功能。
J Clin Transl Endocrinol. 2022 Nov 13;30:100311. doi: 10.1016/j.jcte.2022.100311. eCollection 2022 Dec.

本文引用的文献

1
Diabetes as a determinant of mortality in cystic fibrosis.糖尿病作为囊性纤维化患者死亡的决定因素。
Diabetes Care. 2010 Feb;33(2):311-6. doi: 10.2337/dc09-1215. Epub 2009 Nov 16.
2
Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.囊性纤维化患者的早期葡萄糖异常先于体重增长不良。
Diabetes Care. 2010 Feb;33(2):221-6. doi: 10.2337/dc09-1492. Epub 2009 Nov 12.
3
Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.胰岛素治疗改善无空腹高血糖的囊性纤维化相关糖尿病患者的体重指数:囊性纤维化相关糖尿病治疗试验的结果
Diabetes Care. 2009 Oct;32(10):1783-8. doi: 10.2337/dc09-0585. Epub 2009 Jul 10.
4
Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.囊性纤维化相关糖尿病:患病率、发病率和死亡率的当前趋势
Diabetes Care. 2009 Sep;32(9):1626-31. doi: 10.2337/dc09-0586. Epub 2009 Jun 19.
5
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.糖尿病预防试验1型参与者中的血糖异常事件及进展为1型糖尿病的情况
Diabetes Care. 2009 Sep;32(9):1603-7. doi: 10.2337/dc08-2140. Epub 2009 Jun 1.
6
One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.为期一年的甘精胰岛素治疗可改善患有囊性纤维化及早期血糖紊乱的儿童和青少年的肺部疾病病程。
Pediatr Diabetes. 2009 May;10(3):162-7. doi: 10.1111/j.1399-5448.2008.00451.x. Epub 2009 Jan 14.
7
Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention.囊性纤维化相关糖尿病患者的营养状况下降:强化营养干预的效果
J Cyst Fibros. 2009 May;8(3):179-85. doi: 10.1016/j.jcf.2008.12.002.
8
Management of cystic fibrosis-related diabetes.囊性纤维化相关糖尿病的管理
Pediatr Diabetes. 2008 Jul 28;9(4 Pt 1):338-44. doi: 10.1111/j.1399-5448.2008.00437.x.
9
Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.囊性纤维化患者的葡萄糖耐量、胰岛素分泌、发病率及死亡率
J Pediatr. 2008 Apr;152(4):540-5, 545.e1. doi: 10.1016/j.jpeds.2007.09.025. Epub 2007 Nov 26.
10
Long-term effect of insulin treatment in cystic fibrosis-related diabetes.胰岛素治疗对囊性纤维化相关糖尿病的长期影响。
Respiration. 2008;76(2):181-6. doi: 10.1159/000110206. Epub 2007 Oct 25.